RFC
RXII

Russell Frank Company’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Russell Frank Company’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-35,263
Closed -$88K – 2974
2014
Q1 		$88K Sell
35,263
-112,165
-76% -$280K ﹤0.01% 2695
2013
Q4 		$781K Buy
147,428
+146,982
+32,956% +$779K ﹤0.01% 2173
2013
Q3 		$1K Buy
+446
New +$1K ﹤0.01% 3437

Other funds holding RXII

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Russell Frank Company's RXII Position: Q2 2014 in Review

Russell Frank Company sold out of GALENA BIOPHARMA INC COM (RXII) in Q2 2014, closing a stake of 35,263 shares — an estimated $88K sold.

Russell Frank Company first reported a position in RXII in Q3 2013 and held it in 3 quarters. The position peaked at $781K in Q4 2013. 90 funds tracked by Wall St. Rank hold RXII as of Q2 2014.

  • Russell Frank Company reported no remaining GALENA BIOPHARMA INC COM position as of Q2 2014 after selling out during the quarter.
  • Russell Frank Company sold 35,263 GALENA BIOPHARMA INC COM shares in Q2 2014, an estimated $88K.
  • Russell Frank Company first reported a position in GALENA BIOPHARMA INC COM in Q3 2013 and held it in 3 quarters.
  • Russell Frank Company's GALENA BIOPHARMA INC COM position peaked at $781K in Q4 2013.
  • 90 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q2 2014.

Based on Russell Frank Company's 13F filing for Q2 2014, filed 14 Aug 2014.